|
85 Companies |
|
108 Products |
|
108 Products |
|
99 Mechanisms of Action |
|
9 Trials |
|
2118 News |
|
| 12345678910111213...4041» |
- | NN1213 / Novo Nordisk
Trial completion, MRI: Intracoronary Thrombus Detection by Magnetic Resonance Imaging (clinicaltrials.gov) - Jun 21, 2024
P=N/A, N=40, Completed, Sponsor: University of Edinburgh
Suspended --> Completed
- | Enrollment change, Trial withdrawal, MRI, Inflammatory cell: Inflammatory Cell Trafficking After Myocardial Infarction (clinicaltrials.gov) - May 1, 2024
P=N/A, N=0, Withdrawn, Sponsor: University of Edinburgh
Suspended --> Completed N=66 --> 0 | Suspended --> Withdrawn
- | Enrollment change: PATCAR: Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization (clinicaltrials.gov) - Sep 6, 2023
P4, N=390, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=66 --> 0 | Suspended --> Withdrawn N=254 --> 390
- | NN1213 / Novo Nordisk
Trial completion date: Effect of Family-Centered Empowerment Model (clinicaltrials.gov) - Jun 6, 2023
P=N/A, N=70, Completed, Sponsor: Baqiyatallah Medical Sciences University
N=254 --> 390 Trial completion date: Jan 2015 --> Jan 2023
- | NN1213 / Novo Nordisk
Trial completion: SPIDERFLASH: Prospective Study Evaluating the Interest of Long-term Cardiac Recording in Cerebral Infarction (clinicaltrials.gov) - Apr 25, 2019
P=N/A, N=108, Completed, Sponsor: Groupe Hospitalier Paris Saint Joseph
Trial completion date: Jan 2015 --> Jan 2023 Active, not recruiting --> Completed
- ||||| deramiocel (CAP-1002) / Capricor, Lonza, Nippon Shinyaku
Trial completion date, Trial termination: ALLSTAR: Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (clinicaltrials.gov) - Apr 20, 2019
P1/2, N=156, Terminated, Sponsor: Capricor Inc.
Active, not recruiting --> Completed Trial completion date: Jul 2021 --> Feb 2019 | Active, not recruiting --> Terminated; On February 28, 2019, Capricor ceased ongoing follow-up activities and terminated the ALLSTAR trial to focus resourcing on its active CAP-1002 program, HOPE-2.
- | Trial completion, Trial completion date: Renal Acute MI Study (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=50, Completed, Sponsor: Monash University
Trial completion date: Jul 2021 --> Feb 2019 | Active, not recruiting --> Terminated; On February 28, 2019, Capricor ceased ongoing follow-up activities and terminated the ALLSTAR trial to focus resourcing on its active CAP-1002 program, HOPE-2. Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Sep 2018
- | cilostazol / Generic mfg.
Phase classification: Cilostazol Stroke Prevention Study for Antiplatelet Combination (clinicaltrials.gov) - Apr 20, 2019
P4, N=1884, Completed, Sponsor: Japan Cardiovascular Research Foundation
Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Sep 2018 Phase classification: P3 --> P4
- | ticagrelor / Generic mfg.
Enrollment change: Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome (clinicaltrials.gov) - Apr 19, 2019
P4, N=148, Terminated, Sponsor: Yonsei University
Phase classification: P3 --> P4 N=444 --> 148
- | colchicine / Generic mfg.
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Mechanistic Effects of Colchicine in Patients With Myocardial Infarction (clinicaltrials.gov) - Apr 18, 2019
P4, N=0, Withdrawn, Sponsor: New York University School of Medicine
N=444 --> 148 N=19 --> 0 | Trial completion date: Jan 2018 --> Sep 2018 | Completed --> Withdrawn | Trial primary completion date: Jan 2018 --> Sep 2018
- ||| NN1213 / Novo Nordisk
Trial completion: Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (clinicaltrials.gov) - Apr 16, 2019
P=N/A, N=500, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=19 --> 0 | Trial completion date: Jan 2018 --> Sep 2018 | Completed --> Withdrawn | Trial primary completion date: Jan 2018 --> Sep 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Multi-modality Imaging in Acute Myocardial Infarction (clinicaltrials.gov) - Apr 10, 2019
P=N/A, N=62, Completed, Sponsor: William Beaumont Hospitals
Active, not recruiting --> Completed Recruiting --> Completed | N=100 --> 62 | Trial completion date: Jun 2020 --> Feb 2019 | Trial primary completion date: Jun 2019 --> Feb 2019
- | Trial completion, Trial completion date: STATIM: Cooling in Myocardial Infarction (clinicaltrials.gov) - Mar 14, 2019
P=N/A, N=120, Completed, Sponsor: Medical University of Vienna
Recruiting --> Completed | N=100 --> 62 | Trial completion date: Jun 2020 --> Feb 2019 | Trial primary completion date: Jun 2019 --> Feb 2019 Active, not recruiting --> Completed | Trial completion date: Jul 2017 --> Jan 2019
- | NN1213 / Novo Nordisk
Trial completion: HEART Pathway Implementation (clinicaltrials.gov) - Mar 4, 2019
P=N/A, N=14717, Completed, Sponsor: Wake Forest University Health Sciences
Active, not recruiting --> Completed | Trial completion date: Jul 2017 --> Jan 2019 Active, not recruiting --> Completed
- | ticagrelor / Generic mfg., clopidogrel / Generic mfg.
Trial completion, Head-to-Head: Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis (clinicaltrials.gov) - Feb 15, 2019
P3, N=3799, Completed, Sponsor: Hospital do Coracao
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | dexmedetomidine / Generic mfg.
Enrollment change, Trial withdrawal: Effect of Sedatives on Regional Cerebral Oxygen Saturation (clinicaltrials.gov) - Feb 15, 2019
P=N/A, N=0, Withdrawn, Sponsor: Gachon University Gil Medical Center
Active, not recruiting --> Completed N=60 --> 0 | Recruiting --> Withdrawn
- | NN1213 / Novo Nordisk
Trial completion date: SPIDERFLASH: Prospective Study Evaluating the Interest of Long-term Cardiac Recording in Cerebral Infarction (clinicaltrials.gov) - Feb 4, 2019
P=N/A, N=108, Active, not recruiting, Sponsor: Groupe Hospitalier Paris Saint Joseph
N=60 --> 0 | Recruiting --> Withdrawn Trial completion date: Dec 2018 --> Mar 2019
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: SAFARI-STEMI: Femoral Versus Radial Access for Primary PCI (clinicaltrials.gov) - Jan 29, 2019
P=N/A, N=2292, Completed, Sponsor: Ottawa Heart Institute Research Corporation
Trial completion date: Dec 2018 --> Mar 2019 Recruiting --> Completed | N=4884 --> 2292 | Trial completion date: Apr 2020 --> Jan 2019 | Trial primary completion date: Aug 2019 --> Dec 2018
- | NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: RACE-STEMI: Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients With STEMI (clinicaltrials.gov) - Jan 23, 2019
P3, N=200, Not yet recruiting, Sponsor: American Heart of Poland
Recruiting --> Completed | N=4884 --> 2292 | Trial completion date: Apr 2020 --> Jan 2019 | Trial primary completion date: Aug 2019 --> Dec 2018 Trial completion date: Dec 2018 --> Dec 2022 | Trial primary completion date: Jul 2018 --> Jul 2022
- | Trial completion, Trial completion date, Trial primary completion date: OUT-ACS: One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome (clinicaltrials.gov) - Jan 17, 2019
P=N/A, N=1750, Completed, Sponsor: Oslo University Hospital
Trial completion date: Dec 2018 --> Dec 2022 | Trial primary completion date: Jul 2018 --> Jul 2022 Recruiting --> Completed | Trial completion date: Dec 2017 --> Oct 2018 | Trial primary completion date: Dec 2017 --> Oct 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: RIC-STEMI: Remote Ischemic Conditioning in ST-elevation Myocardial Infarction as Adjuvant to Primary Angioplasty (clinicaltrials.gov) - Jan 15, 2019
P=N/A, N=516, Completed, Sponsor: Hospital de Braga
Recruiting --> Completed | Trial completion date: Dec 2017 --> Oct 2018 | Trial primary completion date: Dec 2017 --> Oct 2018 Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Dec 2018
- | NN1213 / Novo Nordisk
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Reactivation of Varicella Zoster Virus and Risk of Vascular Disease (clinicaltrials.gov) - Jan 4, 2019
P=N/A, N=0, Withdrawn, Sponsor: University College, London
Active, not recruiting --> Completed | Trial completion date: Dec 2017 --> Dec 2018 | Trial primary completion date: Dec 2017 --> Dec 2018 N=2000 --> 0 | Trial completion date: Dec 2017 --> Jan 2019 | Active, not recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Jan 2019
- | NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: Multi-modality Imaging in Acute Myocardial Infarction (clinicaltrials.gov) - Jan 4, 2019
P=N/A, N=100, Recruiting, Sponsor: William Beaumont Hospitals
N=2000 --> 0 | Trial completion date: Dec 2017 --> Jan 2019 | Active, not recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Jan 2019 Trial completion date: Jan 2020 --> Jun 2020 | Trial primary completion date: Jan 2019 --> Jun 2019
- | colchicine / Generic mfg.
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Mechanistic Effects of Colchicine in Patients With Myocardial Infarction (clinicaltrials.gov) - Jan 3, 2019
P4, N=19, Completed, Sponsor: New York University School of Medicine
Trial completion date: Jan 2020 --> Jun 2020 | Trial primary completion date: Jan 2019 --> Jun 2019 Recruiting --> Completed | N=60 --> 19 | Trial completion date: Dec 2018 --> Jan 2018 | Trial primary completion date: Dec 2018 --> Jan 2018
- ||||||| cilostazol / Generic mfg.
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Cilostazol Stroke Prevention Study for Antiplatelet Combination (clinicaltrials.gov) - Dec 27, 2018
P3, N=1884, Completed, Sponsor: Japan Cardiovascular Research Foundation
Recruiting --> Completed | N=60 --> 19 | Trial completion date: Dec 2018 --> Jan 2018 | Trial primary completion date: Dec 2018 --> Jan 2018 Recruiting --> Completed | N=4000 --> 1884 | Trial completion date: Mar 2017 --> Dec 2018 | Trial primary completion date: Mar 2017 --> Dec 2018
- | Trial completion, Phase classification: NORSTENT: Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis (clinicaltrials.gov) - Dec 24, 2018
P=N/A, N=9013, Completed, Sponsor: University of Tromso
Recruiting --> Completed | N=4000 --> 1884 | Trial completion date: Mar 2017 --> Dec 2018 | Trial primary completion date: Mar 2017 --> Dec 2018 Active, not recruiting --> Completed | Phase classification: P4 --> PN/A
- || BMS-986141 / BMS
Trial completion: Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" (clinicaltrials.gov) - Dec 14, 2018
P2, N=16, Completed, Sponsor: Bristol-Myers Squibb
Active, not recruiting --> Completed | Phase classification: P4 --> PN/A Terminated --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: Affect of Health Education on Statins Medication Persistence and ClinicaL Prognosis of Ischemic Stroke Patients (HELP) (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=3111, Completed, Sponsor: yongjun wang
Terminated --> Completed Not yet recruiting --> Completed | N=1500 --> 3111
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: Affect of Multiple Health Education on Medication Persistence and Clinical Prognosis of Ischemic Stroke Patients (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=3111, Completed, Sponsor: yongjun wang
Not yet recruiting --> Completed | N=1500 --> 3111 Not yet recruiting --> Completed | N=1800 --> 3111
- ||| Trial completion: ST LEUIS: Smartphone Twelve Lead Electrocardiogram Utility In ST-Elevation Myocardial Infarction (clinicaltrials.gov) - Dec 7, 2018
P=N/A, N=50, Completed, Sponsor: Mayo Clinic
Not yet recruiting --> Completed | N=1800 --> 3111 Active, not recruiting --> Completed
- | Trial completion: TheBox: The Box: Using Smart Technology to Improve One-year Outcome of Myocardial Infarction Patients (clinicaltrials.gov) - Dec 6, 2018
P=N/A, N=200, Completed, Sponsor: Leiden University Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || Stemedyne-MSC (human bone marrow-derived ischemia tolerant mesenchymal cells) / Stemedica Cell Technologies
Trial completion: A Study of Allogeneic Mesenchymal Bone Marrow Cells in Subjects With Ischemic Stroke (clinicaltrials.gov) - Dec 3, 2018
P1/2, N=38, Completed, Sponsor: Stemedica Cell Technologies, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: BARDA II: Identify Clinical Conditions That Increase Circulating DNA Levels (clinicaltrials.gov) - Nov 21, 2018
P=N/A, N=130, Completed, Sponsor: University of Florida
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jul 2019 --> Jul 2016 | Trial primary completion date: Oct 2018 --> Jul 2016
- | NN1213 / Novo Nordisk
Trial completion: Curative Efficacy of Secondary Prevention for Patients With Ischemic Stroke Through Syndrome Differentiation of TCM (clinicaltrials.gov) - Nov 19, 2018
P4, N=2200, Completed, Sponsor: Xiaofei Yu
Active, not recruiting --> Completed | Trial completion date: Jul 2019 --> Jul 2016 | Trial primary completion date: Oct 2018 --> Jul 2016 Recruiting --> Completed
- | 3K3A-APC / ZZ Biotech
Trial completion date, Combination therapy: RHAPSODY: Safety Evaluation of 3K3A-APC in Ischemic Stroke (clinicaltrials.gov) - Nov 8, 2018
P2, N=110, Completed, Sponsor: ZZ Biotech, LLC
Recruiting --> Completed Trial completion date: Oct 2017 --> Jun 2017
- | NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: HEART Pathway Implementation (clinicaltrials.gov) - Nov 2, 2018
P=N/A, N=14717, Active, not recruiting, Sponsor: Wake Forest University Health Sciences
Trial completion date: Oct 2017 --> Jun 2017 Trial completion date: Oct 2018 --> Mar 2019 | Trial primary completion date: Oct 2018 --> Jan 2019
- | Kengreal (cangrelor) / Chiesi
Trial completion, Trial completion date, Trial primary completion date: The Effect of IV Cangrelor and Oral Ticagrelor Study (clinicaltrials.gov) - Oct 31, 2018
P4, N=100, Completed, Sponsor: The Royal Wolverhampton Hospitals NHS Trust
Trial completion date: Oct 2018 --> Mar 2019 | Trial primary completion date: Oct 2018 --> Jan 2019 Recruiting --> Completed | Trial completion date: Feb 2019 --> Oct 2018 | Trial primary completion date: Feb 2018 --> Oct 2018
- | Xience (everolimus-eluting stent) / Abbott
Trial completion: BIOSCIENCE: Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents (clinicaltrials.gov) - Oct 18, 2018
P=N/A, N=2119, Completed, Sponsor: University Hospital Inselspital, Berne
Recruiting --> Completed | Trial completion date: Feb 2019 --> Oct 2018 | Trial primary completion date: Feb 2018 --> Oct 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion: Cologne Register of Wearable Defibrillator (CRWD) (clinicaltrials.gov) - Oct 18, 2018
P=N/A, N=100, Completed, Sponsor: University of Cologne
Active, not recruiting --> Completed Recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: EXIT-V: Effect of Exercise Training on Left Ventricular Function in Patients Post Myocardial Infarction (clinicaltrials.gov) - Oct 18, 2018
P=N/A, N=26, Completed, Sponsor: Montreal Heart Institute
Recruiting --> Completed Recruiting --> Completed | N=20 --> 26 | Trial completion date: Aug 2016 --> Oct 2018 | Trial primary completion date: Jul 2016 --> Feb 2016
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation (clinicaltrials.gov) - Oct 15, 2018
P=N/A, N=11, Completed, Sponsor: University of Alberta
Recruiting --> Completed | N=20 --> 26 | Trial completion date: Aug 2016 --> Oct 2018 | Trial primary completion date: Jul 2016 --> Feb 2016 Recruiting --> Completed | N=20 --> 11 | Trial completion date: May 2018 --> Dec 2017 | Trial primary completion date: May 2018 --> Dec 2017
- | NN1213 / Novo Nordisk
Trial completion: Feasability of Collaborative Care in the Secondary Prevention of Coronary Heart Disease (clinicaltrials.gov) - Oct 11, 2018
P=N/A, N=40, Completed, Sponsor: University of G
Recruiting --> Completed | N=20 --> 11 | Trial completion date: May 2018 --> Dec 2017 | Trial primary completion date: May 2018 --> Dec 2017 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Reasons for Prehospital Delay in Patients With Acute Ischemic Stroke (clinicaltrials.gov) - Oct 10, 2018
P=N/A, N=337, Completed, Sponsor: University Hospital, Basel, Switzerland
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Sep 2018 --> Nov 2017 | Trial primary completion date: Sep 2018 --> Nov 2017
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: CPORT: Cardiovascular Patient Outcomes and Research Team Primary PCI Registry (clinicaltrials.gov) - Oct 4, 2018
P=N/A, N=6726, Completed, Sponsor: Johns Hopkins University
Recruiting --> Completed | Trial completion date: Sep 2018 --> Nov 2017 | Trial primary completion date: Sep 2018 --> Nov 2017 Recruiting --> Completed | Trial completion date: Mar 2016 --> Dec 2015
- | Ilaris (canakinumab) / Novartis
Trial completion: Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP) (clinicaltrials.gov) - Oct 2, 2018
P=N/A, N=16, Completed, Sponsor: Virginia Commonwealth University
Recruiting --> Completed | Trial completion date: Mar 2016 --> Dec 2015 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke (clinicaltrials.gov) - Oct 2, 2018
P2, N=78, Completed, Sponsor: Hocheol Kim
Active, not recruiting --> Completed Recruiting --> Completed | N=141 --> 78 | Trial completion date: Oct 2017 --> Aug 2018 | Trial primary completion date: Oct 2017 --> Aug 2018
- | clopidogrel / Generic mfg.
Trial completion, Enrollment change: Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial) (clinicaltrials.gov) - Sep 13, 2018
P=N/A, N=167, Completed, Sponsor: North Texas Veterans Healthcare System
Recruiting --> Completed | N=141 --> 78 | Trial completion date: Oct 2017 --> Aug 2018 | Trial primary completion date: Oct 2017 --> Aug 2018 Active, not recruiting --> Completed | N=280 --> 167
- | Phase classification, Combination therapy: ReCCLAIM II: Reperfusion With Cooling in Cerebral Acute Ischemia II (clinicaltrials.gov) - Sep 13, 2018
P=N/A, N=0, Withdrawn, Sponsor: WellStar Health System
Active, not recruiting --> Completed | N=280 --> 167 Phase classification: P2 --> P=N/A
- | Phase classification: A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke (clinicaltrials.gov) - Sep 13, 2018
P=N/A, N=198, Completed, Sponsor: Penumbra Inc.
Phase classification: P2 --> P=N/A Phase classification: P2/3 --> P=N/A
- | Trial termination: PET/CT Study in the Diagnosis of Coronary Plaque (clinicaltrials.gov) - Aug 29, 2018
P=N/A, N=3, Terminated, Sponsor: Washington University School of Medicine
Phase classification: P2/3 --> P=N/A Completed --> Terminated; Sub-investigator left the university